avapritinib
blueprint medicines
['pathfinder']
mced panel #aacr23 bradbury: want to collect data in a registry. wood: the diagnostic workup is complex. pathfinder study had a recommended workup dep on tissue of origin.
Business development, marketing and sales professional in the life sciences, cancer diagnostics, and genomics fields. Blog: https://t.co/IeMzCogxlt. Opinions are my own.